_________
false
כן-פייט ביופרמה בע"מ
2
380
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
4329
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
10/08/2023
www.isa.gov.il
www.tase.co.il
Reference:
2023-02-092520
Time of broadcast:
16:43
16:43
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
_________
ea182824-6k_xtlbiopharmaEDGAR3_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
08/08/2023
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
KANTOR RONEN
Position of Signatory in the reporting corporation:
External Legal Counsel
Name of Employer Company:
Address:
Metzada
7
,
Bnei Brak
5126112
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@DTKGC.com
1